Skip to main content

CORRECTION article

Front. Endocrinol., 04 May 2023
Sec. Adrenal Endocrinology
Volume 14 - 2023 | https://doi.org/10.3389/fendo.2023.1210892

Corrigendum: Challenges in the treatment of late-identified untreated congenital adrenal hyperplasia due to CYP11B1 deficiency: Lessons from a developing country

This article is a correction to:

  1. Challenges in the treatment of late-identified untreated congenital adrenal hyperplasia due to CYP11B1 deficiency: Lessons from a developing country

    1. Read original article
Agustini Utari,*Agustini Utari1,2*Sultana M. H. FaradzSultana M. H. Faradz1Annastasia Ediati,Annastasia Ediati1,3Tuula RinneTuula Rinne4Mahayu Dewi ArianiMahayu Dewi Ariani1Achmad Zulfa JuniartoAchmad Zulfa Juniarto1Stenvert L. S. DropStenvert L. S. Drop5Antonius E. van HerwaardenAntonius E. van Herwaarden6Hedi L. Claahsen-van der GrintenHedi L. Claahsen-van der Grinten7
  • 1Center for Biomedical Research (CEBIOR), Faculty of Medicine, Diponegoro University, Semarang, Indonesia
  • 2Division of Pediatric Endocrinology, Department of Pediatrics, Faculty of Medicine, Diponegoro University, Semarang, Indonesia
  • 3Faculty of Psychology, Diponegoro University, Semarang, Indonesia
  • 4Department of Human Genetics, Radboud University Medical Center, Nijmegen, Netherlands
  • 5Division of Pediatric Endocrinology, Sophia Children’s Hospital and Erasmus Medical Center, Rotterdam, Netherlands
  • 6Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen, Netherlands
  • 7Division of Pediatric Endocrinology, Department of Pediatrics, Amalia Children’s Hospital, Radboud University Medical Center, Nijmegen, Netherlands

A corrigendum on
Challenges in the treatment of late-identified untreated congenital adrenal hyperplasia due to CYP11B1 deficiency: Lessons from a developing country

by Utari A, Faradz SMH, Ediati A, Rinne T, Ariani MD, Juniarto AZ, Drop SLS, van Herwaarden AE and Claahsen-van der Grinten HL (2022) Front. Endocrinol. 13:1015973. doi: 10.3389/fendo.2022.1015973

In the published article, there was an error in the Acknowledgments statement. The following sentence was missing from the statement and has now been added.

“The presented work resulted from collaboration made possible through the ESPE sponsored programme “ESPE Visiting Professorship” supported by Pfizer.”

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: congenital adrenal hyperplasia, CYP11B1 deficiency, differences (disorders) of sex development, developing country, guideline

Citation: Utari A, Faradz SMH, Ediati A, Rinne T, Ariani MD, Juniarto AZ, Drop SLS, van Herwaarden AE and Claahsen-van der Grinten HL (2023) Corrigendum: Challenges in the treatment of late-identified untreated congenital adrenal hyperplasia due to CYP11B1 deficiency: Lessons from a developing country. Front. Endocrinol. 14:1210892. doi: 10.3389/fendo.2023.1210892

Received: 23 April 2023; Accepted: 25 April 2023;
Published: 04 May 2023.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2023 Utari, Faradz, Ediati, Rinne, Ariani, Juniarto, Drop, van Herwaarden and Claahsen-van der Grinten. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Agustini Utari, YWd1c3Rpbml1dGFyaUBnbWFpbC5jb20=

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.